Global Live Attenuated Polio Vaccine Supply, Demand and Key Producers, 2026-2032
The global Live Attenuated Polio Vaccine market size is expected to reach $ 282 million by 2032, rising at a market growth of 2.2% CAGR during the forecast period (2026-2032).
Live Attenuated Polio Vaccine is an oral preventive biological product produced from artificially attenuated poliovirus strains through viral culture, harvest, purification or clarification, stabilizer formulation, and filling. By mimicking natural intestinal infection, it induces both humoral immunity and intestinal mucosal immunity, helping prevent poliomyelitis infection and interrupt virus transmission within populations. Depending on the virus types included, it can be classified as trivalent, bivalent, or monovalent oral polio vaccine. Its use strategy changes across different stages of global polio eradication, depending on wild poliovirus circulation, vaccine-derived poliovirus risks, and immunization program adjustments. Compared with inactivated vaccines, live attenuated polio vaccines offer convenient oral administration, strong herd-immunity effects, and suitability for large-scale emergency campaigns and transmission interruption, making them one of the most influential vaccine categories in the history of global polio control.In 2025, global Live Attenuated Polio Vaccine production reached approximately 200 million doses.The average gross profit margin of this product is 55%.
The market value of live attenuated polio vaccines mainly comes from transmission interruption needs in the final stage of global polio eradication, immunization accessibility in developing countries, and public health emergency preparedness. OPV offers oral administration, ease of use, suitability for mass population coverage, and strong intestinal mucosal immunity. In regions where wild poliovirus transmission or vaccine-derived poliovirus outbreaks remain a risk, it continues to be an important tool for rapidly building community protection. WHO?s prequalification of novel oral polio vaccine type 2 shows that the global market is not simply abandoning OPV, but optimizing its emergency-use value through improved genetic stability and safety. For manufacturers, live attenuated polio vaccine is not merely a low-price public health product, but a strategic category connected to national immunization programs, international organization procurement, outbreak response, and the global polio eradication agenda.
The core challenges of this industry lie in safety pressure during the post-eradication stage, shrinking routine-use scenarios, and higher regulatory requirements. OPV contains live attenuated virus. Although it has strong advantages in herd immunity and transmission interruption, in areas with low immunization coverage, vaccine strains may circulate for extended periods and accumulate genetic changes. As a result, global immunization strategies are gradually shifting from broad reliance on OPV toward staged and scenario-specific coordination between IPV and OPV. China CDC documents also show that immunization schedules emphasize sequential use of IPV and bOPV rather than reliance on OPV alone. Manufacturers must maintain high standards in strain genetic stability, viral titer control, stabilizer systems, cold-chain storage and transportation, batch release, and post-marketing safety monitoring, while facing demand-structure changes and capacity utilization uncertainty caused by policy adjustments.
Downstream demand is shifting from broad routine use toward sequential use in immunization programs, supplementary immunization in key regions, outbreak response, and international public health procurement. Disease control systems focus on whether products can rapidly cover large populations, interrupt fecal-oral transmission chains, and coordinate effectively with IPV-based schedules. International organizations and developing-country markets place greater emphasis on supply stability, affordability, cold-chain adaptability, and field vaccination efficiency. As global polio control enters a more refined stage, routine demand for traditional OPV may gradually decline, but novel and more stable OPV products will retain critical value in localized outbreak control and public health emergency response. Future competitiveness will increasingly be reflected in public health response capability, international certification, and global supply chain coordination.
This report studies the global Live Attenuated Polio Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Live Attenuated Polio Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Live Attenuated Polio Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Live Attenuated Polio Vaccine total production and demand, 2021-2032, (K Dose)
Global Live Attenuated Polio Vaccine total production value, 2021-2032, (USD Million)
Global Live Attenuated Polio Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Live Attenuated Polio Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Live Attenuated Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Live Attenuated Polio Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Live Attenuated Polio Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Live Attenuated Polio Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Live Attenuated Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute (Bilthoven Biologicals), Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Live Attenuated Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Live Attenuated Polio Vaccine Market, By Region:
1. How big is the global Live Attenuated Polio Vaccine market?
2. What is the demand of the global Live Attenuated Polio Vaccine market?
3. What is the year over year growth of the global Live Attenuated Polio Vaccine market?
4. What is the production and production value of the global Live Attenuated Polio Vaccine market?
5. Who are the key producers in the global Live Attenuated Polio Vaccine market?
6. What are the growth factors driving the market demand?
Live Attenuated Polio Vaccine is an oral preventive biological product produced from artificially attenuated poliovirus strains through viral culture, harvest, purification or clarification, stabilizer formulation, and filling. By mimicking natural intestinal infection, it induces both humoral immunity and intestinal mucosal immunity, helping prevent poliomyelitis infection and interrupt virus transmission within populations. Depending on the virus types included, it can be classified as trivalent, bivalent, or monovalent oral polio vaccine. Its use strategy changes across different stages of global polio eradication, depending on wild poliovirus circulation, vaccine-derived poliovirus risks, and immunization program adjustments. Compared with inactivated vaccines, live attenuated polio vaccines offer convenient oral administration, strong herd-immunity effects, and suitability for large-scale emergency campaigns and transmission interruption, making them one of the most influential vaccine categories in the history of global polio control.In 2025, global Live Attenuated Polio Vaccine production reached approximately 200 million doses.The average gross profit margin of this product is 55%.
The market value of live attenuated polio vaccines mainly comes from transmission interruption needs in the final stage of global polio eradication, immunization accessibility in developing countries, and public health emergency preparedness. OPV offers oral administration, ease of use, suitability for mass population coverage, and strong intestinal mucosal immunity. In regions where wild poliovirus transmission or vaccine-derived poliovirus outbreaks remain a risk, it continues to be an important tool for rapidly building community protection. WHO?s prequalification of novel oral polio vaccine type 2 shows that the global market is not simply abandoning OPV, but optimizing its emergency-use value through improved genetic stability and safety. For manufacturers, live attenuated polio vaccine is not merely a low-price public health product, but a strategic category connected to national immunization programs, international organization procurement, outbreak response, and the global polio eradication agenda.
The core challenges of this industry lie in safety pressure during the post-eradication stage, shrinking routine-use scenarios, and higher regulatory requirements. OPV contains live attenuated virus. Although it has strong advantages in herd immunity and transmission interruption, in areas with low immunization coverage, vaccine strains may circulate for extended periods and accumulate genetic changes. As a result, global immunization strategies are gradually shifting from broad reliance on OPV toward staged and scenario-specific coordination between IPV and OPV. China CDC documents also show that immunization schedules emphasize sequential use of IPV and bOPV rather than reliance on OPV alone. Manufacturers must maintain high standards in strain genetic stability, viral titer control, stabilizer systems, cold-chain storage and transportation, batch release, and post-marketing safety monitoring, while facing demand-structure changes and capacity utilization uncertainty caused by policy adjustments.
Downstream demand is shifting from broad routine use toward sequential use in immunization programs, supplementary immunization in key regions, outbreak response, and international public health procurement. Disease control systems focus on whether products can rapidly cover large populations, interrupt fecal-oral transmission chains, and coordinate effectively with IPV-based schedules. International organizations and developing-country markets place greater emphasis on supply stability, affordability, cold-chain adaptability, and field vaccination efficiency. As global polio control enters a more refined stage, routine demand for traditional OPV may gradually decline, but novel and more stable OPV products will retain critical value in localized outbreak control and public health emergency response. Future competitiveness will increasingly be reflected in public health response capability, international certification, and global supply chain coordination.
This report studies the global Live Attenuated Polio Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Live Attenuated Polio Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Live Attenuated Polio Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Live Attenuated Polio Vaccine total production and demand, 2021-2032, (K Dose)
Global Live Attenuated Polio Vaccine total production value, 2021-2032, (USD Million)
Global Live Attenuated Polio Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Live Attenuated Polio Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Live Attenuated Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Live Attenuated Polio Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Live Attenuated Polio Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Live Attenuated Polio Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Live Attenuated Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute (Bilthoven Biologicals), Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Live Attenuated Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Live Attenuated Polio Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Conventional OPV
- Novel OPV
- Monovalent
- Bivalent
- Trivalent
- Oral Drops
- Sugar Pill
- Hospital
- Clinic
- Others
- Sanofi
- GSK
- Bibcol
- Serum Institute (Bilthoven Biologicals)
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
1. How big is the global Live Attenuated Polio Vaccine market?
2. What is the demand of the global Live Attenuated Polio Vaccine market?
3. What is the year over year growth of the global Live Attenuated Polio Vaccine market?
4. What is the production and production value of the global Live Attenuated Polio Vaccine market?
5. Who are the key producers in the global Live Attenuated Polio Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Live Attenuated Polio Vaccine Introduction
1.2 World Live Attenuated Polio Vaccine Supply & Forecast
1.2.1 World Live Attenuated Polio Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Live Attenuated Polio Vaccine Production (2021-2032)
1.2.3 World Live Attenuated Polio Vaccine Pricing Trends (2021-2032)
1.3 World Live Attenuated Polio Vaccine Production by Region (Based on Production Site)
1.3.1 World Live Attenuated Polio Vaccine Production Value by Region (2021-2032)
1.3.2 World Live Attenuated Polio Vaccine Production by Region (2021-2032)
1.3.3 World Live Attenuated Polio Vaccine Average Price by Region (2021-2032)
1.3.4 North America Live Attenuated Polio Vaccine Production (2021-2032)
1.3.5 Europe Live Attenuated Polio Vaccine Production (2021-2032)
1.3.6 China Live Attenuated Polio Vaccine Production (2021-2032)
1.3.7 Japan Live Attenuated Polio Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Live Attenuated Polio Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Live Attenuated Polio Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Live Attenuated Polio Vaccine Demand (2021-2032)
2.2 World Live Attenuated Polio Vaccine Consumption by Region
2.2.1 World Live Attenuated Polio Vaccine Consumption by Region (2021-2026)
2.2.2 World Live Attenuated Polio Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Live Attenuated Polio Vaccine Consumption (2021-2032)
2.4 China Live Attenuated Polio Vaccine Consumption (2021-2032)
2.5 Europe Live Attenuated Polio Vaccine Consumption (2021-2032)
2.6 Japan Live Attenuated Polio Vaccine Consumption (2021-2032)
2.7 South Korea Live Attenuated Polio Vaccine Consumption (2021-2032)
2.8 ASEAN Live Attenuated Polio Vaccine Consumption (2021-2032)
2.9 India Live Attenuated Polio Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Live Attenuated Polio Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Live Attenuated Polio Vaccine Production by Manufacturer (2021-2026)
3.3 World Live Attenuated Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Live Attenuated Polio Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Live Attenuated Polio Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Live Attenuated Polio Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Live Attenuated Polio Vaccine in 2025
3.6 Live Attenuated Polio Vaccine Market: Overall Company Footprint Analysis
3.6.1 Live Attenuated Polio Vaccine Market: Region Footprint
3.6.2 Live Attenuated Polio Vaccine Market: Company Product Type Footprint
3.6.3 Live Attenuated Polio Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Live Attenuated Polio Vaccine Production Value Comparison
4.1.1 United States VS China: Live Attenuated Polio Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Live Attenuated Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Live Attenuated Polio Vaccine Production Comparison
4.2.1 United States VS China: Live Attenuated Polio Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Live Attenuated Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Live Attenuated Polio Vaccine Consumption Comparison
4.3.1 United States VS China: Live Attenuated Polio Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Live Attenuated Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Live Attenuated Polio Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Live Attenuated Polio Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Live Attenuated Polio Vaccine Production (2021-2026)
4.5 China Based Live Attenuated Polio Vaccine Manufacturers and Market Share
4.5.1 China Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Live Attenuated Polio Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Live Attenuated Polio Vaccine Production (2021-2026)
4.6 Rest of World Based Live Attenuated Polio Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Live Attenuated Polio Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Conventional OPV
5.2.2 Novel OPV
5.3 Market Segment by Type
5.3.1 World Live Attenuated Polio Vaccine Production by Type (2021-2032)
5.3.2 World Live Attenuated Polio Vaccine Production Value by Type (2021-2032)
5.3.3 World Live Attenuated Polio Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VIRUS TYPE
6.1 World Live Attenuated Polio Vaccine Market Size Overview by Virus Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Virus Type
6.2.1 Monovalent
6.2.2 Bivalent
6.2.3 Trivalent
6.3 Market Segment by Virus Type
6.3.1 World Live Attenuated Polio Vaccine Production by Virus Type (2021-2032)
6.3.2 World Live Attenuated Polio Vaccine Production Value by Virus Type (2021-2032)
6.3.3 World Live Attenuated Polio Vaccine Average Price by Virus Type (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Live Attenuated Polio Vaccine Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral Drops
7.2.2 Sugar Pill
7.3 Market Segment by Dosage Form
7.3.1 World Live Attenuated Polio Vaccine Production by Dosage Form (2021-2032)
7.3.2 World Live Attenuated Polio Vaccine Production Value by Dosage Form (2021-2032)
7.3.3 World Live Attenuated Polio Vaccine Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Live Attenuated Polio Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Live Attenuated Polio Vaccine Production by Application (2021-2032)
8.3.2 World Live Attenuated Polio Vaccine Production Value by Application (2021-2032)
8.3.3 World Live Attenuated Polio Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Live Attenuated Polio Vaccine Product and Services
9.1.4 Sanofi Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK Live Attenuated Polio Vaccine Product and Services
9.2.4 GSK Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 Bibcol
9.3.1 Bibcol Details
9.3.2 Bibcol Major Business
9.3.3 Bibcol Live Attenuated Polio Vaccine Product and Services
9.3.4 Bibcol Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bibcol Recent Developments/Updates
9.3.6 Bibcol Competitive Strengths & Weaknesses
9.4 Serum Institute (Bilthoven Biologicals)
9.4.1 Serum Institute (Bilthoven Biologicals) Details
9.4.2 Serum Institute (Bilthoven Biologicals) Major Business
9.4.3 Serum Institute (Bilthoven Biologicals) Live Attenuated Polio Vaccine Product and Services
9.4.4 Serum Institute (Bilthoven Biologicals) Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
9.4.6 Serum Institute (Bilthoven Biologicals) Competitive Strengths & Weaknesses
9.5 Tiantan Biological
9.5.1 Tiantan Biological Details
9.5.2 Tiantan Biological Major Business
9.5.3 Tiantan Biological Live Attenuated Polio Vaccine Product and Services
9.5.4 Tiantan Biological Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Tiantan Biological Recent Developments/Updates
9.5.6 Tiantan Biological Competitive Strengths & Weaknesses
9.6 IMBCA
9.6.1 IMBCA Details
9.6.2 IMBCA Major Business
9.6.3 IMBCA Live Attenuated Polio Vaccine Product and Services
9.6.4 IMBCA Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 IMBCA Recent Developments/Updates
9.6.6 IMBCA Competitive Strengths & Weaknesses
9.7 Panacea Biotec Ltd
9.7.1 Panacea Biotec Ltd Details
9.7.2 Panacea Biotec Ltd Major Business
9.7.3 Panacea Biotec Ltd Live Attenuated Polio Vaccine Product and Services
9.7.4 Panacea Biotec Ltd Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Panacea Biotec Ltd Recent Developments/Updates
9.7.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
9.8 Bio-Med
9.8.1 Bio-Med Details
9.8.2 Bio-Med Major Business
9.8.3 Bio-Med Live Attenuated Polio Vaccine Product and Services
9.8.4 Bio-Med Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Bio-Med Recent Developments/Updates
9.8.6 Bio-Med Competitive Strengths & Weaknesses
9.9 Halfkin Bio-Pharmaceuticals
9.9.1 Halfkin Bio-Pharmaceuticals Details
9.9.2 Halfkin Bio-Pharmaceuticals Major Business
9.9.3 Halfkin Bio-Pharmaceuticals Live Attenuated Polio Vaccine Product and Services
9.9.4 Halfkin Bio-Pharmaceuticals Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
9.9.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Live Attenuated Polio Vaccine Industry Chain
10.2 Live Attenuated Polio Vaccine Upstream Analysis
10.2.1 Live Attenuated Polio Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Live Attenuated Polio Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Live Attenuated Polio Vaccine Production Mode
10.6 Live Attenuated Polio Vaccine Procurement Model
10.7 Live Attenuated Polio Vaccine Industry Sales Model and Sales Channels
10.7.1 Live Attenuated Polio Vaccine Sales Model
10.7.2 Live Attenuated Polio Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Live Attenuated Polio Vaccine Introduction
1.2 World Live Attenuated Polio Vaccine Supply & Forecast
1.2.1 World Live Attenuated Polio Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Live Attenuated Polio Vaccine Production (2021-2032)
1.2.3 World Live Attenuated Polio Vaccine Pricing Trends (2021-2032)
1.3 World Live Attenuated Polio Vaccine Production by Region (Based on Production Site)
1.3.1 World Live Attenuated Polio Vaccine Production Value by Region (2021-2032)
1.3.2 World Live Attenuated Polio Vaccine Production by Region (2021-2032)
1.3.3 World Live Attenuated Polio Vaccine Average Price by Region (2021-2032)
1.3.4 North America Live Attenuated Polio Vaccine Production (2021-2032)
1.3.5 Europe Live Attenuated Polio Vaccine Production (2021-2032)
1.3.6 China Live Attenuated Polio Vaccine Production (2021-2032)
1.3.7 Japan Live Attenuated Polio Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Live Attenuated Polio Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Live Attenuated Polio Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Live Attenuated Polio Vaccine Demand (2021-2032)
2.2 World Live Attenuated Polio Vaccine Consumption by Region
2.2.1 World Live Attenuated Polio Vaccine Consumption by Region (2021-2026)
2.2.2 World Live Attenuated Polio Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Live Attenuated Polio Vaccine Consumption (2021-2032)
2.4 China Live Attenuated Polio Vaccine Consumption (2021-2032)
2.5 Europe Live Attenuated Polio Vaccine Consumption (2021-2032)
2.6 Japan Live Attenuated Polio Vaccine Consumption (2021-2032)
2.7 South Korea Live Attenuated Polio Vaccine Consumption (2021-2032)
2.8 ASEAN Live Attenuated Polio Vaccine Consumption (2021-2032)
2.9 India Live Attenuated Polio Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Live Attenuated Polio Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Live Attenuated Polio Vaccine Production by Manufacturer (2021-2026)
3.3 World Live Attenuated Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Live Attenuated Polio Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Live Attenuated Polio Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Live Attenuated Polio Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Live Attenuated Polio Vaccine in 2025
3.6 Live Attenuated Polio Vaccine Market: Overall Company Footprint Analysis
3.6.1 Live Attenuated Polio Vaccine Market: Region Footprint
3.6.2 Live Attenuated Polio Vaccine Market: Company Product Type Footprint
3.6.3 Live Attenuated Polio Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Live Attenuated Polio Vaccine Production Value Comparison
4.1.1 United States VS China: Live Attenuated Polio Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Live Attenuated Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Live Attenuated Polio Vaccine Production Comparison
4.2.1 United States VS China: Live Attenuated Polio Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Live Attenuated Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Live Attenuated Polio Vaccine Consumption Comparison
4.3.1 United States VS China: Live Attenuated Polio Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Live Attenuated Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Live Attenuated Polio Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Live Attenuated Polio Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Live Attenuated Polio Vaccine Production (2021-2026)
4.5 China Based Live Attenuated Polio Vaccine Manufacturers and Market Share
4.5.1 China Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Live Attenuated Polio Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Live Attenuated Polio Vaccine Production (2021-2026)
4.6 Rest of World Based Live Attenuated Polio Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Live Attenuated Polio Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Conventional OPV
5.2.2 Novel OPV
5.3 Market Segment by Type
5.3.1 World Live Attenuated Polio Vaccine Production by Type (2021-2032)
5.3.2 World Live Attenuated Polio Vaccine Production Value by Type (2021-2032)
5.3.3 World Live Attenuated Polio Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY VIRUS TYPE
6.1 World Live Attenuated Polio Vaccine Market Size Overview by Virus Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Virus Type
6.2.1 Monovalent
6.2.2 Bivalent
6.2.3 Trivalent
6.3 Market Segment by Virus Type
6.3.1 World Live Attenuated Polio Vaccine Production by Virus Type (2021-2032)
6.3.2 World Live Attenuated Polio Vaccine Production Value by Virus Type (2021-2032)
6.3.3 World Live Attenuated Polio Vaccine Average Price by Virus Type (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Live Attenuated Polio Vaccine Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral Drops
7.2.2 Sugar Pill
7.3 Market Segment by Dosage Form
7.3.1 World Live Attenuated Polio Vaccine Production by Dosage Form (2021-2032)
7.3.2 World Live Attenuated Polio Vaccine Production Value by Dosage Form (2021-2032)
7.3.3 World Live Attenuated Polio Vaccine Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Live Attenuated Polio Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Live Attenuated Polio Vaccine Production by Application (2021-2032)
8.3.2 World Live Attenuated Polio Vaccine Production Value by Application (2021-2032)
8.3.3 World Live Attenuated Polio Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi Live Attenuated Polio Vaccine Product and Services
9.1.4 Sanofi Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 GSK
9.2.1 GSK Details
9.2.2 GSK Major Business
9.2.3 GSK Live Attenuated Polio Vaccine Product and Services
9.2.4 GSK Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK Recent Developments/Updates
9.2.6 GSK Competitive Strengths & Weaknesses
9.3 Bibcol
9.3.1 Bibcol Details
9.3.2 Bibcol Major Business
9.3.3 Bibcol Live Attenuated Polio Vaccine Product and Services
9.3.4 Bibcol Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bibcol Recent Developments/Updates
9.3.6 Bibcol Competitive Strengths & Weaknesses
9.4 Serum Institute (Bilthoven Biologicals)
9.4.1 Serum Institute (Bilthoven Biologicals) Details
9.4.2 Serum Institute (Bilthoven Biologicals) Major Business
9.4.3 Serum Institute (Bilthoven Biologicals) Live Attenuated Polio Vaccine Product and Services
9.4.4 Serum Institute (Bilthoven Biologicals) Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
9.4.6 Serum Institute (Bilthoven Biologicals) Competitive Strengths & Weaknesses
9.5 Tiantan Biological
9.5.1 Tiantan Biological Details
9.5.2 Tiantan Biological Major Business
9.5.3 Tiantan Biological Live Attenuated Polio Vaccine Product and Services
9.5.4 Tiantan Biological Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Tiantan Biological Recent Developments/Updates
9.5.6 Tiantan Biological Competitive Strengths & Weaknesses
9.6 IMBCA
9.6.1 IMBCA Details
9.6.2 IMBCA Major Business
9.6.3 IMBCA Live Attenuated Polio Vaccine Product and Services
9.6.4 IMBCA Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 IMBCA Recent Developments/Updates
9.6.6 IMBCA Competitive Strengths & Weaknesses
9.7 Panacea Biotec Ltd
9.7.1 Panacea Biotec Ltd Details
9.7.2 Panacea Biotec Ltd Major Business
9.7.3 Panacea Biotec Ltd Live Attenuated Polio Vaccine Product and Services
9.7.4 Panacea Biotec Ltd Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Panacea Biotec Ltd Recent Developments/Updates
9.7.6 Panacea Biotec Ltd Competitive Strengths & Weaknesses
9.8 Bio-Med
9.8.1 Bio-Med Details
9.8.2 Bio-Med Major Business
9.8.3 Bio-Med Live Attenuated Polio Vaccine Product and Services
9.8.4 Bio-Med Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Bio-Med Recent Developments/Updates
9.8.6 Bio-Med Competitive Strengths & Weaknesses
9.9 Halfkin Bio-Pharmaceuticals
9.9.1 Halfkin Bio-Pharmaceuticals Details
9.9.2 Halfkin Bio-Pharmaceuticals Major Business
9.9.3 Halfkin Bio-Pharmaceuticals Live Attenuated Polio Vaccine Product and Services
9.9.4 Halfkin Bio-Pharmaceuticals Live Attenuated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
9.9.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Live Attenuated Polio Vaccine Industry Chain
10.2 Live Attenuated Polio Vaccine Upstream Analysis
10.2.1 Live Attenuated Polio Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Live Attenuated Polio Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Live Attenuated Polio Vaccine Production Mode
10.6 Live Attenuated Polio Vaccine Procurement Model
10.7 Live Attenuated Polio Vaccine Industry Sales Model and Sales Channels
10.7.1 Live Attenuated Polio Vaccine Sales Model
10.7.2 Live Attenuated Polio Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Live Attenuated Polio Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Live Attenuated Polio Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Live Attenuated Polio Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Live Attenuated Polio Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Live Attenuated Polio Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Live Attenuated Polio Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Live Attenuated Polio Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Live Attenuated Polio Vaccine Production Market Share by Region (2021-2026)
Table 9. World Live Attenuated Polio Vaccine Production Market Share by Region (2027-2032)
Table 10. World Live Attenuated Polio Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Live Attenuated Polio Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Live Attenuated Polio Vaccine Major Market Trends
Table 13. World Live Attenuated Polio Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Live Attenuated Polio Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Live Attenuated Polio Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Live Attenuated Polio Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Live Attenuated Polio Vaccine Producers in 2025
Table 18. World Live Attenuated Polio Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Live Attenuated Polio Vaccine Producers in 2025
Table 20. World Live Attenuated Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Live Attenuated Polio Vaccine Company Evaluation Quadrant
Table 22. World Live Attenuated Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Live Attenuated Polio Vaccine Production Site of Key Manufacturer
Table 24. Live Attenuated Polio Vaccine Market: Company Product Type Footprint
Table 25. Live Attenuated Polio Vaccine Market: Company Product Application Footprint
Table 26. Live Attenuated Polio Vaccine Competitive Factors
Table 27. Live Attenuated Polio Vaccine New Entrant and Capacity Expansion Plans
Table 28. Live Attenuated Polio Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Live Attenuated Polio Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Live Attenuated Polio Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Live Attenuated Polio Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Live Attenuated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Live Attenuated Polio Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Live Attenuated Polio Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Live Attenuated Polio Vaccine Production Market Share (2021-2026)
Table 37. China Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Live Attenuated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Live Attenuated Polio Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Live Attenuated Polio Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Live Attenuated Polio Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Market Share (2021-2026)
Table 47. World Live Attenuated Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Live Attenuated Polio Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Live Attenuated Polio Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Live Attenuated Polio Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Live Attenuated Polio Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Live Attenuated Polio Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Live Attenuated Polio Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Live Attenuated Polio Vaccine Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Table 55. World Live Attenuated Polio Vaccine Production by Virus Type (2021-2026) & (K Dose)
Table 56. World Live Attenuated Polio Vaccine Production by Virus Type (2027-2032) & (K Dose)
Table 57. World Live Attenuated Polio Vaccine Production Value by Virus Type (2021-2026) & (USD Million)
Table 58. World Live Attenuated Polio Vaccine Production Value by Virus Type (2027-2032) & (USD Million)
Table 59. World Live Attenuated Polio Vaccine Average Price by Virus Type (2021-2026) & (US$/Dose)
Table 60. World Live Attenuated Polio Vaccine Average Price by Virus Type (2027-2032) & (US$/Dose)
Table 61. World Live Attenuated Polio Vaccine Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Live Attenuated Polio Vaccine Production by Dosage Form (2021-2026) & (K Dose)
Table 63. World Live Attenuated Polio Vaccine Production by Dosage Form (2027-2032) & (K Dose)
Table 64. World Live Attenuated Polio Vaccine Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Live Attenuated Polio Vaccine Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Live Attenuated Polio Vaccine Average Price by Dosage Form (2021-2026) & (US$/Dose)
Table 67. World Live Attenuated Polio Vaccine Average Price by Dosage Form (2027-2032) & (US$/Dose)
Table 68. World Live Attenuated Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Live Attenuated Polio Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Live Attenuated Polio Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Live Attenuated Polio Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Live Attenuated Polio Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Live Attenuated Polio Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Live Attenuated Polio Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Live Attenuated Polio Vaccine Product and Services
Table 78. Sanofi Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK Live Attenuated Polio Vaccine Product and Services
Table 84. GSK Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. Bibcol Basic Information, Manufacturing Base and Competitors
Table 88. Bibcol Major Business
Table 89. Bibcol Live Attenuated Polio Vaccine Product and Services
Table 90. Bibcol Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bibcol Recent Developments/Updates
Table 92. Bibcol Competitive Strengths & Weaknesses
Table 93. Serum?Institute?(Bilthoven?Biologicals) Basic Information, Manufacturing Base and Competitors
Table 94. Serum?Institute?(Bilthoven?Biologicals) Major Business
Table 95. Serum?Institute?(Bilthoven?Biologicals) Live Attenuated Polio Vaccine Product and Services
Table 96. Serum?Institute?(Bilthoven?Biologicals) Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Serum?Institute?(Bilthoven?Biologicals) Recent Developments/Updates
Table 98. Serum?Institute?(Bilthoven?Biologicals) Competitive Strengths & Weaknesses
Table 99. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 100. Tiantan Biological Major Business
Table 101. Tiantan Biological Live Attenuated Polio Vaccine Product and Services
Table 102. Tiantan Biological Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Tiantan Biological Recent Developments/Updates
Table 104. Tiantan Biological Competitive Strengths & Weaknesses
Table 105. IMBCA Basic Information, Manufacturing Base and Competitors
Table 106. IMBCA Major Business
Table 107. IMBCA Live Attenuated Polio Vaccine Product and Services
Table 108. IMBCA Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. IMBCA Recent Developments/Updates
Table 110. IMBCA Competitive Strengths & Weaknesses
Table 111. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 112. Panacea Biotec Ltd Major Business
Table 113. Panacea Biotec Ltd Live Attenuated Polio Vaccine Product and Services
Table 114. Panacea Biotec Ltd Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Panacea Biotec Ltd Recent Developments/Updates
Table 116. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 117. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 118. Bio-Med Major Business
Table 119. Bio-Med Live Attenuated Polio Vaccine Product and Services
Table 120. Bio-Med Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Med Recent Developments/Updates
Table 122. Bio-Med Competitive Strengths & Weaknesses
Table 123. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 124. Halfkin Bio-Pharmaceuticals Major Business
Table 125. Halfkin Bio-Pharmaceuticals Live Attenuated Polio Vaccine Product and Services
Table 126. Halfkin Bio-Pharmaceuticals Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 128. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 129. Global Key Players of Live Attenuated Polio Vaccine Upstream (Raw Materials)
Table 130. Global Live Attenuated Polio Vaccine Typical Customers
Table 131. Live Attenuated Polio Vaccine Typical Distributors
Table 1. World Live Attenuated Polio Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Live Attenuated Polio Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Live Attenuated Polio Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Live Attenuated Polio Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Live Attenuated Polio Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Live Attenuated Polio Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Live Attenuated Polio Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Live Attenuated Polio Vaccine Production Market Share by Region (2021-2026)
Table 9. World Live Attenuated Polio Vaccine Production Market Share by Region (2027-2032)
Table 10. World Live Attenuated Polio Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Live Attenuated Polio Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Live Attenuated Polio Vaccine Major Market Trends
Table 13. World Live Attenuated Polio Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Live Attenuated Polio Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Live Attenuated Polio Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Live Attenuated Polio Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Live Attenuated Polio Vaccine Producers in 2025
Table 18. World Live Attenuated Polio Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Live Attenuated Polio Vaccine Producers in 2025
Table 20. World Live Attenuated Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Live Attenuated Polio Vaccine Company Evaluation Quadrant
Table 22. World Live Attenuated Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Live Attenuated Polio Vaccine Production Site of Key Manufacturer
Table 24. Live Attenuated Polio Vaccine Market: Company Product Type Footprint
Table 25. Live Attenuated Polio Vaccine Market: Company Product Application Footprint
Table 26. Live Attenuated Polio Vaccine Competitive Factors
Table 27. Live Attenuated Polio Vaccine New Entrant and Capacity Expansion Plans
Table 28. Live Attenuated Polio Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Live Attenuated Polio Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Live Attenuated Polio Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Live Attenuated Polio Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Live Attenuated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Live Attenuated Polio Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Live Attenuated Polio Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Live Attenuated Polio Vaccine Production Market Share (2021-2026)
Table 37. China Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Live Attenuated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Live Attenuated Polio Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Live Attenuated Polio Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Live Attenuated Polio Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Live Attenuated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Market Share (2021-2026)
Table 47. World Live Attenuated Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Live Attenuated Polio Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Live Attenuated Polio Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Live Attenuated Polio Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Live Attenuated Polio Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Live Attenuated Polio Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Live Attenuated Polio Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Live Attenuated Polio Vaccine Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Table 55. World Live Attenuated Polio Vaccine Production by Virus Type (2021-2026) & (K Dose)
Table 56. World Live Attenuated Polio Vaccine Production by Virus Type (2027-2032) & (K Dose)
Table 57. World Live Attenuated Polio Vaccine Production Value by Virus Type (2021-2026) & (USD Million)
Table 58. World Live Attenuated Polio Vaccine Production Value by Virus Type (2027-2032) & (USD Million)
Table 59. World Live Attenuated Polio Vaccine Average Price by Virus Type (2021-2026) & (US$/Dose)
Table 60. World Live Attenuated Polio Vaccine Average Price by Virus Type (2027-2032) & (US$/Dose)
Table 61. World Live Attenuated Polio Vaccine Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Live Attenuated Polio Vaccine Production by Dosage Form (2021-2026) & (K Dose)
Table 63. World Live Attenuated Polio Vaccine Production by Dosage Form (2027-2032) & (K Dose)
Table 64. World Live Attenuated Polio Vaccine Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Live Attenuated Polio Vaccine Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Live Attenuated Polio Vaccine Average Price by Dosage Form (2021-2026) & (US$/Dose)
Table 67. World Live Attenuated Polio Vaccine Average Price by Dosage Form (2027-2032) & (US$/Dose)
Table 68. World Live Attenuated Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Live Attenuated Polio Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Live Attenuated Polio Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Live Attenuated Polio Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Live Attenuated Polio Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Live Attenuated Polio Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Live Attenuated Polio Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi Live Attenuated Polio Vaccine Product and Services
Table 78. Sanofi Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. GSK Basic Information, Manufacturing Base and Competitors
Table 82. GSK Major Business
Table 83. GSK Live Attenuated Polio Vaccine Product and Services
Table 84. GSK Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK Recent Developments/Updates
Table 86. GSK Competitive Strengths & Weaknesses
Table 87. Bibcol Basic Information, Manufacturing Base and Competitors
Table 88. Bibcol Major Business
Table 89. Bibcol Live Attenuated Polio Vaccine Product and Services
Table 90. Bibcol Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bibcol Recent Developments/Updates
Table 92. Bibcol Competitive Strengths & Weaknesses
Table 93. Serum?Institute?(Bilthoven?Biologicals) Basic Information, Manufacturing Base and Competitors
Table 94. Serum?Institute?(Bilthoven?Biologicals) Major Business
Table 95. Serum?Institute?(Bilthoven?Biologicals) Live Attenuated Polio Vaccine Product and Services
Table 96. Serum?Institute?(Bilthoven?Biologicals) Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Serum?Institute?(Bilthoven?Biologicals) Recent Developments/Updates
Table 98. Serum?Institute?(Bilthoven?Biologicals) Competitive Strengths & Weaknesses
Table 99. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 100. Tiantan Biological Major Business
Table 101. Tiantan Biological Live Attenuated Polio Vaccine Product and Services
Table 102. Tiantan Biological Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Tiantan Biological Recent Developments/Updates
Table 104. Tiantan Biological Competitive Strengths & Weaknesses
Table 105. IMBCA Basic Information, Manufacturing Base and Competitors
Table 106. IMBCA Major Business
Table 107. IMBCA Live Attenuated Polio Vaccine Product and Services
Table 108. IMBCA Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. IMBCA Recent Developments/Updates
Table 110. IMBCA Competitive Strengths & Weaknesses
Table 111. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 112. Panacea Biotec Ltd Major Business
Table 113. Panacea Biotec Ltd Live Attenuated Polio Vaccine Product and Services
Table 114. Panacea Biotec Ltd Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Panacea Biotec Ltd Recent Developments/Updates
Table 116. Panacea Biotec Ltd Competitive Strengths & Weaknesses
Table 117. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 118. Bio-Med Major Business
Table 119. Bio-Med Live Attenuated Polio Vaccine Product and Services
Table 120. Bio-Med Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Med Recent Developments/Updates
Table 122. Bio-Med Competitive Strengths & Weaknesses
Table 123. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 124. Halfkin Bio-Pharmaceuticals Major Business
Table 125. Halfkin Bio-Pharmaceuticals Live Attenuated Polio Vaccine Product and Services
Table 126. Halfkin Bio-Pharmaceuticals Live Attenuated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 128. Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses
Table 129. Global Key Players of Live Attenuated Polio Vaccine Upstream (Raw Materials)
Table 130. Global Live Attenuated Polio Vaccine Typical Customers
Table 131. Live Attenuated Polio Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Live Attenuated Polio Vaccine Picture
Figure 2. World Live Attenuated Polio Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Live Attenuated Polio Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Live Attenuated Polio Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Live Attenuated Polio Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Live Attenuated Polio Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 12. Live Attenuated Polio Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. World Live Attenuated Polio Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. China Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Europe Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Japan Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. India Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Live Attenuated Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Live Attenuated Polio Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Live Attenuated Polio Vaccine Markets in 2025
Figure 26. United States VS China: Live Attenuated Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Live Attenuated Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Live Attenuated Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Live Attenuated Polio Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers Live Attenuated Polio Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Market Share 2025
Figure 32. World Live Attenuated Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Live Attenuated Polio Vaccine Production Value Market Share by Type in 2025
Figure 34. Conventional OPV
Figure 35. Novel OPV
Figure 36. World Live Attenuated Polio Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Live Attenuated Polio Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Live Attenuated Polio Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World Live Attenuated Polio Vaccine Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Figure 40. World Live Attenuated Polio Vaccine Production Value Market Share by Virus Type in 2025
Figure 41. Monovalent
Figure 42. Bivalent
Figure 43. Trivalent
Figure 44. World Live Attenuated Polio Vaccine Production Market Share by Virus Type (2021-2032)
Figure 45. World Live Attenuated Polio Vaccine Production Value Market Share by Virus Type (2021-2032)
Figure 46. World Live Attenuated Polio Vaccine Average Price by Virus Type (2021-2032) & (US$/Dose)
Figure 47. World Live Attenuated Polio Vaccine Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 48. World Live Attenuated Polio Vaccine Production Value Market Share by Dosage Form in 2025
Figure 49. Oral Drops
Figure 50. Sugar Pill
Figure 51. World Live Attenuated Polio Vaccine Production Market Share by Dosage Form (2021-2032)
Figure 52. World Live Attenuated Polio Vaccine Production Value Market Share by Dosage Form (2021-2032)
Figure 53. World Live Attenuated Polio Vaccine Average Price by Dosage Form (2021-2032) & (US$/Dose)
Figure 54. World Live Attenuated Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Live Attenuated Polio Vaccine Production Value Market Share by Application in 2025
Figure 56. Hospital
Figure 57. Clinic
Figure 58. Others
Figure 59. World Live Attenuated Polio Vaccine Production Market Share by Application (2021-2032)
Figure 60. World Live Attenuated Polio Vaccine Production Value Market Share by Application (2021-2032)
Figure 61. World Live Attenuated Polio Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 62. Live Attenuated Polio Vaccine Industry Chain
Figure 63. Live Attenuated Polio Vaccine Procurement Model
Figure 64. Live Attenuated Polio Vaccine Sales Model
Figure 65. Live Attenuated Polio Vaccine Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
Figure 1. Live Attenuated Polio Vaccine Picture
Figure 2. World Live Attenuated Polio Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Live Attenuated Polio Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Live Attenuated Polio Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Live Attenuated Polio Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Live Attenuated Polio Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Live Attenuated Polio Vaccine Production (2021-2032) & (K Dose)
Figure 12. Live Attenuated Polio Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. World Live Attenuated Polio Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. China Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Europe Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Japan Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. India Live Attenuated Polio Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Live Attenuated Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Live Attenuated Polio Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Live Attenuated Polio Vaccine Markets in 2025
Figure 26. United States VS China: Live Attenuated Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Live Attenuated Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Live Attenuated Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Live Attenuated Polio Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers Live Attenuated Polio Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Live Attenuated Polio Vaccine Production Market Share 2025
Figure 32. World Live Attenuated Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Live Attenuated Polio Vaccine Production Value Market Share by Type in 2025
Figure 34. Conventional OPV
Figure 35. Novel OPV
Figure 36. World Live Attenuated Polio Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Live Attenuated Polio Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Live Attenuated Polio Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World Live Attenuated Polio Vaccine Production Value by Virus Type, (USD Million), 2021 & 2025 & 2032
Figure 40. World Live Attenuated Polio Vaccine Production Value Market Share by Virus Type in 2025
Figure 41. Monovalent
Figure 42. Bivalent
Figure 43. Trivalent
Figure 44. World Live Attenuated Polio Vaccine Production Market Share by Virus Type (2021-2032)
Figure 45. World Live Attenuated Polio Vaccine Production Value Market Share by Virus Type (2021-2032)
Figure 46. World Live Attenuated Polio Vaccine Average Price by Virus Type (2021-2032) & (US$/Dose)
Figure 47. World Live Attenuated Polio Vaccine Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 48. World Live Attenuated Polio Vaccine Production Value Market Share by Dosage Form in 2025
Figure 49. Oral Drops
Figure 50. Sugar Pill
Figure 51. World Live Attenuated Polio Vaccine Production Market Share by Dosage Form (2021-2032)
Figure 52. World Live Attenuated Polio Vaccine Production Value Market Share by Dosage Form (2021-2032)
Figure 53. World Live Attenuated Polio Vaccine Average Price by Dosage Form (2021-2032) & (US$/Dose)
Figure 54. World Live Attenuated Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Live Attenuated Polio Vaccine Production Value Market Share by Application in 2025
Figure 56. Hospital
Figure 57. Clinic
Figure 58. Others
Figure 59. World Live Attenuated Polio Vaccine Production Market Share by Application (2021-2032)
Figure 60. World Live Attenuated Polio Vaccine Production Value Market Share by Application (2021-2032)
Figure 61. World Live Attenuated Polio Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 62. Live Attenuated Polio Vaccine Industry Chain
Figure 63. Live Attenuated Polio Vaccine Procurement Model
Figure 64. Live Attenuated Polio Vaccine Sales Model
Figure 65. Live Attenuated Polio Vaccine Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
